Skip to content
Screener

Veracyte VCYT Operating Lease Liabilities (Total)

Operating Lease Liabilities (Total) at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
$89.9M-10.7%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
$24.98M-1.4%
Personalis, Inc. logo
Personalis, Inc.PSNL
$37.9M-8.9%
Guardant Health logo
Guardant HealthGH
$201.09M+5.8%
Natera, Inc. logo
Natera, Inc.NTRA
$158.2M+36.6%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$174.8M+4.3%

Other financials

Income statement

See full
Revenue$139.1M+21.5%
Gross profit$101.2M+27.2%
Operating income$22.6M+680%
Net income$28.7M+307%
EPS (diluted)$0.35+289%

Balance sheet

See full
Cash & equivalents$264.8M+41.0%
Total debt$39.3M-22.1%
Total equity$1.3B+12.5%
Total assets$1.4B+9.2%

Cash flow

See full
Operating cash flow$35.2M+557%
CapEx$3.0M+62.8%
Free cash flow$32.3M+810%

Valuation

See full
Market cap$3.71B+97.6%
Enterprise value$3.48B+104%
P/E42.2×-29.1×
P/S6.9×+2.9×

Profitability

See full
Gross margin70.9%+2.9pp
Operating margin14.3%+9.2pp
Net margin16.2%+9.1pp
FCF margin28.7%+11.7pp

Returns & leverage

See full
Return on equity6.9%+4.1pp
Debt / equity0.0×
Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.

The source filing: Veracyte’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 8:07 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001384101-26-000031
Year Ending December 31,Amounts
20296,858
20307,055
Thereafter40,405
Total future minimum lease payments71,442
Less: amount representing interest32,109
Present value of future lease payments39,333
Less: short-term lease liabilities4,347
Long-term lease liabilities$34,986

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Veracyte's operating lease liabilities (total)?
Veracyte (VCYT) reported operating lease liabilities (total) of $39.33M in Q1 2026.
How has Veracyte's operating lease liabilities (total) changed year-over-year?
Veracyte's operating lease liabilities (total) decreased by 22.1% year-over-year, from $50.5M to $39.33M.
What is the long-term trend for Veracyte's operating lease liabilities (total)?
Over 5 years (2020 to 2025), Veracyte's operating lease liabilities (total) has grown at a 28.1% compound annual growth rate (CAGR), from $11.51M to $39.65M.
What does operating lease liabilities (total) mean?
This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.

Ask your AI about Veracyte's operating lease liabilities (total).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude